Acute Respiratory Distress Syndrome (ARDS) Market Size, Development, Key Opportunity, Application & Forecast to 2030
Acute Respiratory Distress Syndrome (Ards) Market is expected to portray promising scenarios, as it is estimated to reach $934.8 million in 2030 which was initially valued at around $583.9 million in 2021, thereby registering a CAGR of nearly 6% from 2022 to 2030.
During the COVID-19 epidemic, the Acute Respiratory Distress Syndrome (ARDS) Market has played a critical role. To deal with the...
0 Comments
0 Shares